9.2 C
New York
Wednesday, February 8, 2023

Are Things Looking Up For Elevance Health Inc. (NYSE: ELV)?

After Hours

The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. After-hours trades for Elevance Health Inc. (ELV) shows that investor sentiment remained intact, with the stock’s consolidated last price rising by $1.52, or 0.32%, to $477.00. The Elevance Health Inc. has recorded 49,299 volume in the after hours trading session. Yahoo Finance discussed the stock recently as it posted Twenty-one Elevance Health Medicaid Plans Receive NCQA Health Equity Accreditation.

Top 5 Undervalued Stocks To Own In 2023

Microchip Maker Releases "World's Most Powerful Data Center CPU". It could allow the company who manufactures it to lead the industry as the global microchip shortage continues into the coming year. We've put together a free research report that explains all the details. Not only will you find out why analysts believe this chip manufacturer could lead the pack, you will also discover four more potential winners for the coming year.

Click here to download your Free Research Report…


Stocks Info

The company is listed on the NYSE and operates within the Healthcare Plans industry segment. At the end of the last regular session, the stock closed at $475.48 and fluctuated between $477.93 as its day high and $464.64 as its day low. The current market capitalization of Elevance Health Inc. is $112.96B. A total of 2.33 million shares were traded on the day, compared to an average of 1.14M shares.

Furthermore, investors take into consideration insider trades when predicting a stock’s future trajectory. During the recent three months, ELV has seen 1 BUY and 4 SELL insider trades, representing the acquisition of 200 and the disposition of 10,396 shares. Over the last 12 months, there were 37 BUYs and 35 SELLs from insiders. Insiders purchased 101,466 shares during that period but sold 80,073.


The dividend paying company demonstrates a positive outlook for investors and helps them generate immediate cash. Elevance Health Inc. pays an annual dividend of $5.12, resulting in a dividend yield of 1.08%, and it has a price to earnings (P/E) ratio of 18.66. ELV’s most recent ex-dividend date was 12/2/2022 when it declared a $1.28 quarterly dividend that was paid in cash on 12/21/2022. Previously, the company paid the dividend on 9/23/2022 with an ex-dividend date of 9/8/2022. The ELV stock dividend was $1.28 per share in cash.

It has been observed that price targets are rarely accurate, but they can exert some influence from time to time, and are often accepted as valuable in the market. According to analysts who have offered 12-month price targets for ELV in the last 3 months, the mean price target is $567.33 with high estimates of $620.00 and low estimates of $335.00. In terms of 52-week highs and lows, ELV has a high of $549.52 and a low of $420.73.

As of this writing, ELV has an earnings estimate of $5.2 per share for the current quarter. EPS was calculated based on a consensus of 19 estimates, with a high estimate of $5.32 per share and a lower estimate of $5.12. The company reported an EPS of $8.04 in the last quarter, which was 3.90% higher than expectations of $7.74.

Balance Sheet Annually/Quarterly

An equity investor’s investment can be viewed on a balance sheet by looking at what assets and liabilities the company has. Investors can determine the company’s prospects by calculating its financial ratios based on this information.

Analysts Opinion

There may be slightly higher risks associated with pre-market and after-hours trading than during regular market hours. Due to the fact that issuers often announce critical financial information outside of regular trading hours, extended-hours trading may result in wider spreads for particular securities. Currently, 24 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for ELV is Sell with a score of 4.85. A total of 17 analysts rated the stock as Buy while 2 rated it as Overweight while 5 rated it as Hold. Among the other participants, 0 thought the stock was Underweight and 0 thought it should be Sold.

Related Articles


Please enter your comment!
Please enter your name here

Latest Articles